[{"Assets_0_FY_USD":2503891000.0,"CommonStockSharesOutstanding_0_FY_shares":48287346.0,"EarningsPerShareBasic_4_FY_USD":-0.52,"EarningsPerShareDiluted_1_FY_USD":-2.32,"EarningsPerShareDiluted_4_FY_USD":-0.52,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":91339000.0,"NetIncomeLoss_1_FY_USD":-111688000.0,"NetIncomeLoss_4_FY_USD":-25089000.0,"StockholdersEquity_0_FY_USD":1815314000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":48501000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":48157000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180228"}]